What ARIAD PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Bickerstaff George | Director | Feb 16 | Disposition to Issuer · D | −18,008 | — | — | 0 |
| Protopapas Anna | Director | Feb 16 | Disposition to Issuer · D | −41,910 | — | — | 0 |
| Denner Alexander J | Director | Feb 16 | Disposition to Issuer · D | −5,051,335 | — | — | 0 |
| Denner Alexander J | Director | Feb 16 | Disposition to Issuer · D | −7,798,665 | — | — | 0 |
| Denner Alexander J | Director | Feb 16 | Disposition to Issuer · D | −53,173 | — | — | 0 |
| Haimovitz Jules | Director | Feb 16 | Disposition to Issuer · D | −18,008 | — | — | 0 |
| Soni Manmeet Singh | EVP, CFO & Treasurer | Feb 16 | Disposition to Issuer · D | −3,273 | — | — | 0 |
| Riedel Norbert G | Director | Feb 16 | Disposition to Issuer · D | −139,867 | — | — | 0 |
| Schlesinger Sarah J. | Director | Feb 16 | Disposition to Issuer · D | −55,508 | — | — | 0 |
| Bollag Daniel M | Sr. VP, Reg. Affairs & Quality | Feb 16 | Disposition to Issuer · D | −126,352 | — | — | 0 |
| Panayiotopoulos Paris | President and CEO | Feb 16 | Disposition to Issuer · D | −159,378 | — | — | 0 |
| Herron Jennifer Lyn | Exec V.P. Chief Comm'l Officer | Feb 16 | Disposition to Issuer · D | −450 | — | — | 0 |
| Cole Hugh M | SVP, Chief Business Officer | Feb 16 | Disposition to Issuer · D | −42,834 | — | — | 0 |
| Clackson Timothy P | President, R&D, CSO | Feb 16 | Disposition to Issuer · D | −577 | — | — | 0 |
| Clackson Timothy P | President, R&D, CSO | Feb 16 | Disposition to Issuer · D | −219,867 | — | — | 0 |
| Schlesinger Sarah J. | Director | Feb 13 | Gift · G | −15,600 | — | — | 0 |
| Riedel Norbert G | Director | Jan 31 | Grant / award · A | +12,500 | — | — | 139,867 |
| Riedel Norbert G | Director | Jan 31 | Grant / award · A | +5,508 | — | — | 127,367 |
| Protopapas Anna | Director | Jan 31 | Grant / award · A | +12,500 | — | — | 41,910 |
| Protopapas Anna | Director | Jan 31 | Grant / award · A | +5,508 | — | — | 29,410 |
Loading...